227 related articles for article (PubMed ID: 34747904)
21. Pharmacogenetics in psychiatric care, a call for uptake of available applications.
Lunenburg CATC; Gasse C
Psychiatry Res; 2020 Oct; 292():113336. PubMed ID: 32739644
[TBL] [Abstract][Full Text] [Related]
22. Acute pharmacogenetic dystonic reactions in a family with the CYP2D6 *41 allele: a case report.
Wong DY; Fogel BL
J Med Case Rep; 2021 Aug; 15(1):432. PubMed ID: 34407866
[TBL] [Abstract][Full Text] [Related]
23. The landscape of pharmacogenetic testing in a US managed care population.
Anderson HD; Crooks KR; Kao DP; Aquilante CL
Genet Med; 2020 Jul; 22(7):1247-1253. PubMed ID: 32291400
[TBL] [Abstract][Full Text] [Related]
24. Impact of Pharmacogenomics on Pediatric Psychotropic Medication Prescribing in an Ambulatory Care Setting.
Tonti E; Lee YM; Gruenke N; Ferren J; Stutzman DL
J Child Adolesc Psychopharmacol; 2024 Feb; 34(1):52-60. PubMed ID: 38377527
[No Abstract] [Full Text] [Related]
25. Case report: Avoiding intolerance to antipsychotics through a personalized treatment approach based on pharmacogenetics.
Korošec Hudnik L; Blagus T; Redenšek Trampuž S; Dolžan V; Bon J; Pjevac M
Front Psychiatry; 2024; 15():1363051. PubMed ID: 38566958
[TBL] [Abstract][Full Text] [Related]
26. Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing.
Cavallari LH; Van Driest SL; Prows CA; Bishop JR; Limdi NA; Pratt VM; Ramsey LB; Smith DM; Tuteja S; Duong BQ; Hicks JK; Lee JC; Obeng AO; Beitelshees AL; Bell GC; Blake K; Crona DJ; Dressler L; Gregg RA; Hines LJ; Scott SA; Shelton RC; Weitzel KW; Johnson JA; Peterson JF; Empey PE; Skaar TC;
Genet Med; 2019 Oct; 21(10):2255-2263. PubMed ID: 30894703
[TBL] [Abstract][Full Text] [Related]
27. Prescription Patterns and Relationship to Pharmacogenomics Testing in the Military Health System.
Selig DJ; Livezey JR; Chin GC; DeLuca JP; Guillory Ii WO; Kress AT; Oliver TO; Por ED
Mil Med; 2021 Dec; 187(Suppl 1):9-17. PubMed ID: 34967405
[TBL] [Abstract][Full Text] [Related]
28. Personalized pharmacotherapy in psychiatry.
Filaković P; Petek A
Psychiatr Danub; 2009 Sep; 21(3):341-6. PubMed ID: 19794353
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenetic Testing: Why Is It So Disappointing?
Limandri BJ
J Psychosoc Nurs Ment Health Serv; 2019 Apr; 57(4):9-12. PubMed ID: 30933297
[TBL] [Abstract][Full Text] [Related]
30. Pharmacogenetic testing in psychiatric inpatients with polypharmacy is associated with decreased medication side effects but not via medication changes.
Collins AR; Kung S; Ho JT; Wright JA; Dammen KC; Johnson EK; Lapid MI; Leung JG
J Psychiatr Res; 2020 Jul; 126():105-111. PubMed ID: 32442780
[TBL] [Abstract][Full Text] [Related]
31. A Narrative Review on Pharmacogenomics in Psychiatry: Scientific Definitions, Principles, and Practical Resources.
Palumbo S; Mariotti V; Pellegrini S
J Clin Psychopharmacol; 2024 Jan-Feb 01; 44(1):49-56. PubMed ID: 38100778
[TBL] [Abstract][Full Text] [Related]
32. Pharmacogenetics-based personalized therapy: Levels of evidence and recommendations from the French Network of Pharmacogenetics (RNPGx).
Picard N; Boyer JC; Etienne-Grimaldi MC; Barin-Le Guellec C; Thomas F; Loriot MA;
Therapie; 2017 Apr; 72(2):185-192. PubMed ID: 28237406
[TBL] [Abstract][Full Text] [Related]
33. Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing.
Yang Y; Botton MR; Scott ER; Scott SA
Pharmacogenomics; 2017 May; 18(7):673-685. PubMed ID: 28470112
[TBL] [Abstract][Full Text] [Related]
34. Genetic testing for CYP2D6 and CYP2C19 suggests improved outcome for antidepressant and antipsychotic medication.
Walden LM; Brandl EJ; Tiwari AK; Cheema S; Freeman N; Braganza N; Kennedy JL; Müller DJ
Psychiatry Res; 2019 Sep; 279():111-115. PubMed ID: 29699889
[TBL] [Abstract][Full Text] [Related]
35. Pharmacogenetic Testing Options Relevant to Psychiatry in Canada: Options de tests pharmacogénétiques pertinents en psychiatrie au Canada.
Maruf AA; Fan M; Arnold PD; Müller DJ; Aitchison KJ; Bousman CA
Can J Psychiatry; 2020 Aug; 65(8):521-530. PubMed ID: 32064906
[TBL] [Abstract][Full Text] [Related]
36. Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings.
Chang WC; Tanoshima R; Ross CJD; Carleton BC
Annu Rev Pharmacol Toxicol; 2021 Jan; 61():65-84. PubMed ID: 33006916
[TBL] [Abstract][Full Text] [Related]
37. Pharmacogenetic genotype and phenotype frequencies in a large Danish population-based case-cohort sample.
Lunenburg CATC; Thirstrup JP; Bybjerg-Grauholm J; Bækvad-Hansen M; Hougaard DM; Nordentoft M; Werge T; Børglum AD; Mors O; Mortensen PB; Gasse C
Transl Psychiatry; 2021 May; 11(1):294. PubMed ID: 34006849
[TBL] [Abstract][Full Text] [Related]
38. Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19.
de Leon J; Armstrong SC; Cozza KL
Psychosomatics; 2006; 47(1):75-85. PubMed ID: 16384813
[TBL] [Abstract][Full Text] [Related]
39. [Farmacogenetica in de psychiatrie; de huidige status quo].
van Westrhenen R; Birkenhäger TK
Tijdschr Psychiatr; 2022; 64(5):312-316. PubMed ID: 35735043
[TBL] [Abstract][Full Text] [Related]
40. Current applications of clinical genetic testing for psychiatric practice.
Mrazek DA
Minn Med; 2007 Jan; 90(1):42-3. PubMed ID: 17305105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
